These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15825407)

  • 1. Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.
    Hyams PJ; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1974 Jun; 5(6):571-7. PubMed ID: 15825407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.
    Penner JL; Preston MA; Hennessy JN; Barton LJ; Goodbody MM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):218-21. PubMed ID: 6765415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences among Providencia species in their in vitro susceptibilities to five antibiotics.
    Penner JL; Preston MA
    Antimicrob Agents Chemother; 1980 Dec; 18(6):868-71. PubMed ID: 7235674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.
    Baltimore RS; Klein JO; Wilcox C; Finland M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):701-5. PubMed ID: 1267442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial susceptibilities of clinical isolates of Morganella-proteus-providencia group of bacteria].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1991 Feb; 44(2):140-9. PubMed ID: 2041155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro study of combinations between third-generation cephalosporins and aminoglycosides on Enterobacteriaceae].
    Fosse T; Soussy CJ; Duval J
    Pathol Biol (Paris); 1983 Jun; 31(6):483-7. PubMed ID: 6348654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of "enterobacteria" to aminoglycoside antibiotics: comparisons with tetracyclines, polymyxins, chloramphenicol, and spectinomycin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S57-74. PubMed ID: 184213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro bactericidal effectiveness of four aminoglycoside antibiotics.
    Hyams PJ; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1973 Jan; 3(1):87-94. PubMed ID: 4790579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Ravagnan G
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1644-7. PubMed ID: 3435110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):511-8. PubMed ID: 791104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides.
    Watanakunakorm C; Glotzbecker C
    Antimicrob Agents Chemother; 1974 Dec; 6(6):802-6. PubMed ID: 4451352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides.
    Stephens M; Potten M; Bint AJ
    Infection; 1979; 7(3):109-12. PubMed ID: 478651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.
    Hawkey PM
    J Antimicrob Chemother; 1984 Mar; 13(3):209-26. PubMed ID: 6373713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.